Third Wave Stock Up 13 Percent on Strong Q2 Results | GenomeWeb
NEW YORK (GenomeWeb News) – Shares in Third Wave Technologies were up 13 percent, or $.31, at $2.66 in mid-afternoon trading today after the company said second-quarter revenues increased while net loss narrowed.
 
As GenomeWeb News reported this morning, Third Wave said revenues increased approximately 17 percent and net losses declined. Clinical molecular diagnostic receipts jumped 18 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.